Research

COVID-19 Research

Title :

Stem cell derived exosome therapy for clinical management of lung damage in critically-ill corona viral pneumonia patients

Area of research :

COVID-19 Research, Life Sciences & Biotechnology

Focus area :

Exosome therapy

Principal Investigator :

Dr Naresh Kasoju, Scientist, Sree Chitra Tirunal Institute for Medical Sciences &Technology (SCTIMST), Thiruvananthapuram

Timeline Start Year :

2020

Contact info :

Details

Executive Summary :

This study hypothesized that the immuno-modulatory and the reparative properties of MSC-derived exosomal fractions will aid in controlling the cytokine storm and the lung tissue regeneration in the critically ill COVID-19 patients.

Organizations involved